Physician profile
Steven B Laster
NPI 1386601235
$6,252.37
in general payments reported to CMS, 2019-2025
14 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $96.01 · 2021: $495 · 2022: $682 · 2023: $1,052 · 2024: $1,442 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,721 · Travel and Lodging: $481 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,720.95 |
| Travel and Lodging | $480.57 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,101.84 | 2021-2025 | Resolute Onyx, Symplicity G3, In.Pact Admiral |
| Abbott Laboratories | $754.17 | 2023-2025 | Jeti Peripheral Catheter, Esprit, Jeti |
| Boston Scientific Corporation | $679.32 | 2019-2025 | Avvigo Guidance System, Crossboss |
| Medtronic Vascular, INC. | $474.72 | 2019-2020 | |
| Recor Medical INC | $348.95 | 2025 | Paradise Ultrasound Renal Denervation System |
| Shockwave Medical, INC | $255.69 | 2021-2025 | |
| Terumo Medical Corporation | $153.01 | 2024 | Navicross, Glidewire, Azur Cx Detachable |
| Livanova USA, INC. | $147.92 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $144.07 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $96.48 | 2021 | |
| Angiodynamics, INC. | $54.46 | 2020 | |
| Edwards Lifesciences Corporation | $21.74 | 2025 | Sapien 3 Ultra Resilia |
| Csl Behring | $20.00 | 2024 | Kcentra |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Laster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.